Status: Recruiting
Study of Cryoablation and Nirogacestat for Desmoid Tumor
The primary purpose of this protocol is Systemic therapy with oral study agent, nirogacestat, followed by a single cryoablation procedure.
Participants needed: 28
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Nam BuiUpdated: Sep 8, 2025Locations: 1
Eligibility criteria
Histologically-confirmed diagnosis of desmoid tumor (DT) that is progressing (by... [+25]
Participant previously received or is currently receiving therapy with GS inhibi... [+18]